Elsevier

Pathology

Volume 46, Issue 2, February 2014, Pages 95-104
Pathology

WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition

https://doi.org/10.1097/PAT.0000000000000050Get rights and content

Summary

The fourth edition of the World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone was published in February 2013, and serves to provide an updated classification scheme and reproducible diagnostic criteria for pathologists. Given the relative rarity of soft tissue tumours and the rapid rate of immunohistochemical and genetic/molecular developments (not infrequently facilitating recognition of new tumour entities), this updated text edited by a consensus group is important for both practising pathologists and oncologists. The 2013 WHO classification includes several changes in soft tissue tumour classification, including several new entities (e.g., pseudomyogenic haemangioendothe-lioma, haemosiderotic fibrolipomatous tumour, and acral fibromyxoma), three newly included sections for gastrointestinal stromal tumours, nerve sheath tumours, and undifferentiated/unclassified soft tissue tumours, respectively, various ‘reclassified’ tumours, and a plethora of new genetic and molecular data for established tumour types that facilitate better definition and are useful as diagnostic tools. This article briefly outlines these updates based on the 2013 WHO classification of soft tissue tumours.

References (102)

  • Marshall-TaylorC. et al.

    Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot/ankle

    Mod Pathol

    (2000)
  • FluckeU. et al.

    EWSR1 gene rearrangement occurs in a subset of cutaneous myoepithelial tumors: a study of 18 cases

    Mod Pathol

    (2011)
  • Gebre-MedhinS. et al.

    Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors

    Am J Pathol

    (2012)
  • EndoM. et al.

    Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene

    Hum Pathol

    (2013)
  • WangL. et al.

    Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions

    J Mol Diagn

    (2007)
  • DengF.M. et al.

    Molecular characterization of an EWSR1-POU5F1 fusion associated with a t(6;22) in an undifferentiated soft tissue sarcoma

    Cancer Genet

    (2011)
  • FletcherC.D.M. et al.

    WHO Classification of Tumours of Soft Tissue and Bone. Pathology and Genetics of Tumours of Soft Tissue and Bone

    (2013)
  • HuangD. et al.

    Cllorf95-MKL2 is the resulting fusion oncogene of t(ll;16)(ql3;pl3) in chondroid lipoma

    Genes Chromosomes Cancer

    (2010)
  • FluckeU. et al.

    Presence of Cllorf95-MKL2 fusion is a consistent finding in chondroid lipomas: a study of eight cases

    Histopathology

    (2013)
  • BinhM.B. et al.

    MDM2 and CDK4 immu-nostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data

    Am J Surg Pathol

    (2005)
  • SirventN. et al.

    Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR

    Am J Surg Pathol

    (2007)
  • IdaC.M. et al.

    Primary retroperitoneal lipoma: a soft tissue pathology heresy?: report of a case with classic histologic, cytogenetics, and molecular genetic features

    Am J Surg Pathol

    (2008)
  • MacarencoR.S. et al.

    Retroperitoneal lipomatous tumors without cytologic atypia: are they lipomas? A clin-icopathologic and molecular study of 19 cases

    Am J Surg Pathol

    (2009)
  • Marino-EnriquezA. et al.

    Dedifferentiated liposarcoma with ‘homologous’ lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria

    Am J Surg Pathol

    (2010)
  • LiauJ.Y. et al.

    Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours

    Histopathology

    (2013)
  • OliveiraA.M. et al.

    USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst

    Cancer Res

    (2004)
  • OliveiraA.M. et al.

    Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes

    Oncogene

    (2005)
  • Dal CinP. et al.

    Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas

    Histopathology

    (1997)
  • DahlenA. et al.

    Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors

    Int J Cancer

    (2003)
  • PauwelsP. et al.

    Myofibroblastoma of the breast: genetic link with spindle cell lipoma

    J Pathol

    (2000)
  • MaggianiF. et al.

    Cellular angiofibroma: another mesenchymal tumour with 13ql4 involvement, suggesting a link with spindle cell lipoma and (extra)-mammary myofibroblastoma

    Histopathology

    (2007)
  • BartumaH. et al.

    Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13ql4 deletion

    Genes Chromosomes Cancer

    (2011)
  • ChenB.J. et al.

    Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications

    Am J Surg Pathol

    (2012)
  • ChenE. et al.

    Cellular angiofibroma with atypia or sarcomatous transformation: clinicopathologic analysis of 13 cases

    Am J Surg Pathol

    (2010)
  • RobinsonD.R. et al.

    Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

    Nat Genet

    (2013)
  • MohajeriA. et al.

    Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor

    Genes Chromosomes Cancer

    (2013)
  • SchweizerL. et al.

    Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein

    Acta Neuropathol

    (2013)
  • Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous...
  • HallorK.H. et al.

    Two genetic pathways, t(l;10) and amplification of 3pl 1-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions

    J Pathol

    (2009)
  • AntonescuC.R. et al.

    Consistent t(l;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor

    Genes Chromosomes Cancer

    (2011)
  • ElcoC.P. et al.

    Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link

    Am J Surg Pathol

    (2010)
  • MollerE. et al.

    Mertens F FUS-CREB3L2/Ll-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1

    Clin Cancer Res

    (2011)
  • DoyleL.A. et al.

    MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma

    Am J Surg Pathol

    (2011)
  • DoyleL.A. et al.

    MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement

    Am J Surg Pathol

    (2012)
  • GuillouL. et al.

    Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group

    Am J Surg Pathol

    (2007)
  • Marino-EnriquezA. et al.

    Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK

    Am J Surg Pathol

    (2011)
  • NascimentoA.F. et al.

    Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases

    Am J Surg Pathol

    (2007)
  • HollowoodK. et al.

    Malignant fibrous histiocytoma: morphologic pattern or pathologic entity?

    Semin Diagn Pathol

    (1995)
  • FletcherC.D. et al.

    Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification

    J Clin Oncol

    (2001)
  • WestR.B. et al.

    A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells

    Proc Natl Acad Sci USA

    (2006)
  • Cited by (720)

    • Primary pseudomyogenic hemangioendothelioma of bone on <sup>18</sup>F-FDG PET/MRI

      2024, Revista Espanola de Medicina Nuclear e Imagen Molecular
    View all citing articles on Scopus
    View full text